Covishield and Covaxin market approval

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

India gives conditional market nod for Covishield and Covaxin

People will be able to buy Covishield and Covaxin from hospitals and clinics and the vaccination data have to be updated on Co-Win